Onconova Therapeutics, Inc.

Direct answer

Onconova Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ONTX.

Onconova Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, focused on identifying and advancing innovative therapeutic solutions for oncological diseases. The company's pipeline currently highlights two primary drug candidates undergoing clinical trials: 1. Narazaciclib (ON 123300): This is a multi-targeted kinase inhibitor being evaluated in Phase I studies. It targets both solid...

Can you invest in Onconova Therapeutics, Inc.?

Yes. Onconova Therapeutics, Inc. trades publicly on NASDAQ as ONTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Onconova Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.